- Home
- INDI vs PSNL Comparison
INDI vs PSNL Comparison
Compare INDI & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDI
- PSNL
- Stock Information
- Founded
- INDI 2007
- PSNL 2011
- Country
- INDI United States
- PSNL United States
- Employees
- INDI N/A
- PSNL N/A
- Industry
- INDI Semiconductors
- PSNL Medical Specialities
- Sector
- INDI Technology
- PSNL Health Care
- Exchange
- INDI Nasdaq
- PSNL Nasdaq
- Market Cap
- INDI 881.6M
- PSNL 854.8M
- IPO Year
- INDI N/A
- PSNL 2019
- Fundamental
- Price
- INDI $4.74
- PSNL $8.86
- Analyst Decision
- INDI Strong Buy
- PSNL Strong Buy
- Analyst Count
- INDI 5
- PSNL 5
- Target Price
- INDI $5.90
- PSNL $8.70
- AVG Volume (30 Days)
- INDI 5.7M
- PSNL 1.3M
- Earning Date
- INDI 11-06-2025
- PSNL 11-04-2025
- Dividend Yield
- INDI N/A
- PSNL N/A
- EPS Growth
- INDI N/A
- PSNL N/A
- EPS
- INDI N/A
- PSNL N/A
- Revenue
- INDI $217,685,000.00
- PSNL $80,317,000.00
- Revenue This Year
- INDI $4.53
- PSNL N/A
- Revenue Next Year
- INDI $31.60
- PSNL $29.83
- P/E Ratio
- INDI N/A
- PSNL N/A
- Revenue Growth
- INDI N/A
- PSNL 0.36
- 52 Week Low
- INDI $1.53
- PSNL $2.83
- 52 Week High
- INDI $6.05
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- INDI 44.75
- PSNL 52.03
- Support Level
- INDI $5.37
- PSNL $9.40
- Resistance Level
- INDI $5.97
- PSNL $10.06
- Average True Range (ATR)
- INDI 0.36
- PSNL 0.89
- MACD
- INDI -0.11
- PSNL -0.18
- Stochastic Oscillator
- INDI 1.09
- PSNL 10.20
About INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.